EPL, Inc. specializes in providing high-quality histopathology services, particularly in the realm of preclinical safety testing. With over fifty years of experience since its founding in 1971, the company has established itself as a trusted partner for the scientific community, offering expert toxicologic pathology evaluation and consultation. Their commitment to objectivity and responsiveness has made them a premier source for both industry and government clients seeking reliable and timely pathology services.

The company emphasizes its dedication to meeting the specific needs of its clients, ensuring that their services are not only high-quality but also delivered on time. This focus on excellence has positioned EPL as a leader in the field, capable of addressing the complex challenges associated with preclinical studies. Their reputation for reliability and expertise underscores their role as a vital resource for organizations requiring thorough and accurate toxicologic assessments.

United States

Experimental Pathology Laboratories, Inc. (EPLÂ®) is recognized internationally for its ability to meet the needs of the scientific community and the challenges of preclinical safety testing with high quality, on-time histopathology services. EPLâs wholly owned subsidiary, Aclairo, has seamlessly integrated their efforts with our core histopathology services to provide expert toxicological, pharmacological, DMPK and clinical pharmacology support. Together, we are Experienced Proven Leaders.

EPL, Inc.

Company Details